How have ATRA and INO total returns compared?

Over the past 10 years, ATRA delivered -32.27% and INO delivered -36.78% annualized total return. Past performance doesn't predict future results.

Atara Biotherapeutics, Inc. (ATRA) vs Inovio Pharmaceuticals, Inc. (INO)

A side-by-side comparison of Atara Biotherapeutics, Inc. and Inovio Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ATRA

Atara Biotherapeutics, Inc.

$87M

$9.70HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT

INO

Inovio Pharmaceuticals, Inc.

$79M

$1.14HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

Total return — ATRA vs INO

growth of $100 · dividends reinvested · last 10y

ATRA -98.0% (-32.3%/yr)INO -99.0% (-36.9%/yr)ATRA compounded faster over this window

ATRA INO

ATRA vs INO: by the numbers

•ATRA is the larger company ($87M vs $79M market cap).
•Both run net losses; ATRA's is the smaller (-269.42% vs -130000.00% net margin).

Metrics side by side

Valuation

Metric	ATRA	INO
P/S ratio	14.11	N/A
P/B ratio	N/A	18.02

Profitability

Metric	ATRA	INO
Gross margin	82.44%	100.00%
Operating margin	29.69%	-132871.32%
Net margin	-269.42%	-130000.00%
ROE	N/A	-1542.57%
ROIC	-100.35%	-836.58%

Growth (annualized)

Metric	ATRA	INO
Revenue CAGR (5Y)	56.10%	N/A
Total return CAGR (5Y)	-53.60%	-57.05%

Frequently asked

How have ATRA and INO total returns compared?: Over the past 10 years, ATRA delivered -32.27% and INO delivered -36.78% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ATRA analysis Full INO analysis Interactive comparison tool

Dig into the metrics

Atara Biotherapeutics ROE Inovio Pharmaceuticals ROE Atara Biotherapeutics operating margin Inovio Pharmaceuticals operating margin Atara Biotherapeutics revenue growth Inovio Pharmaceuticals revenue growth Atara Biotherapeutics free cash flow Inovio Pharmaceuticals free cash flow

Atara Biotherapeutics & Inovio Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.